Bionik Laboratories (BNKL) Gross Profit Margin starting from the fourth quarter 2023 to fourth quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Bionik Laboratories Corp   (BNKL)


Bionik Laboratories 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



BNKL Gross Profit Margin (Mar 31 2023)
Q4
(Dec 31 2022)
Q3
(Sep 30 2022)
Q2
(Jun 30 2022)
Q1
(Mar 31 2022)
Q4
Y / Y Revenue Change 158.15 %
Seq. Revenue Change -12.86 %
Revenue In Millions $0.50
Gross Profit Margin 50.71 %
Gross Profit Margin Total Ranking # 1825
Gross Profit In Millions $0.25
Y / Y Gross Profit Change 91.6 %
Seq. Gross Profit Change -6.07 %


Commenting fourth quarter 2023 Gross Profit Margin
Bionik Laboratories Corp increased Gross Profit Margin through reduction in Cost of Sales and despite contraction in Gross Profit by -6.07 % and Revenue by -12.86 %. Gross Profit Margin in Q4 was 50.71 %, below company average.


Observing fourth quarter 2023 results within Medical Equipment & Supplies industry 135 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1825, from total ranking in the previous quarter at 1969.
Learn about Gross Margin
BNKL's Gross Profit Margin fourth quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 136
Healthcare Sector # 351
Overall # 1799

Gross Profit Margin Statistics
High Average Low
94.69 % 58.61 % 9.12 %
(Dec 31 2020)   (Dec 31 2019)




Other Gross Profit Margin Profitability Ratios
BNKL's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
BNKL's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for BNKL's Competitors
Gross Profit Margin Profit Margin for Bionik Laboratories 's Suppliers
Gross Profit Margin Profit Margin for BNKL's Customers

You may also want to know
BNKL's Annual Growth Rates BNKL's Profitability Ratios BNKL's Asset Turnover Ratio BNKL's Dividend Growth
BNKL's Roe BNKL's Valuation Ratios BNKL's Financial Strength Ratios BNKL's Gross Profit Growth
BNKL's Roa BNKL's Inventory Turnover Ratio BNKL's Growth Rates BNKL's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2023, within Medical Equipment & Supplies Industry Gross Profit MarginMar 31 2023 MRQ Gross ProfitMar 31 2023 MRQ Revenue
Aethlon Medical Inc   97.02 %$ 0.557  Millions$ 0.574  Millions
Orchestra Biomed Holdings Inc   96.22 %$ 1.120  Millions$ 1.164  Millions
Docgo Inc   95.51 %$ 77.577  Millions$ 81.226  Millions
Endonovo Therapeutics Inc   95.44 %$ 0.084  Millions$ 0.088  Millions
Semler Scientific inc   93.03 %$ 16.937  Millions$ 18.206  Millions
Vycor Medical Inc   91.47 %$ 0.330  Millions$ 0.361  Millions
Venus Concept Inc   90.08 %$ 13.699  Millions$ 15.207  Millions
Catheter Precision Inc   88.24 %$ 0.075  Millions$ 0.085  Millions
Inari Medical Inc   88.17 %$ 102.426  Millions$ 116.167  Millions
Neuraxis Inc   88.09 %$ 0.709  Millions$ 0.805  Millions
Shockwave Medical Inc   86.92 %$ 140.000  Millions$ 161.066  Millions
Sanara Medtech Inc   86.31 %$ 13.396  Millions$ 15.522  Millions
Inspire Medical Systems inc   84.45 %$ 108.009  Millions$ 127.897  Millions
Avita Medical Inc   84.20 %$ 8.883  Millions$ 10.550  Millions
Fonar Corporation  84.05 %$ 21.366  Millions$ 25.422  Millions
Motus Gi Holdings Inc   83.93 %$ 0.047  Millions$ 0.056  Millions
Sight Sciences Inc   83.81 %$ 15.776  Millions$ 18.824  Millions
Electrocore Inc   83.53 %$ 2.322  Millions$ 2.780  Millions
Cvrx inc   83.36 %$ 6.651  Millions$ 7.979  Millions
Nuo Therapeutics Inc   82.95 %$ 0.051  Millions$ 0.061  Millions
Paragon 28 inc   82.88 %$ 43.130  Millions$ 52.036  Millions
Oak Street Health Inc   82.82 %$ 622.800  Millions$ 752.000  Millions
Mimedx Group Inc   82.67 %$ 59.257  Millions$ 71.676  Millions
Si bone inc   81.89 %$ 26.784  Millions$ 32.708  Millions
Axogen inc   81.70 %$ 29.955  Millions$ 36.664  Millions
Vystar Corporation  81.29 %$ 0.333  Millions$ 0.410  Millions
Treace Medical Concepts Inc   80.95 %$ 34.156  Millions$ 42.195  Millions
Invo Fertility Inc   79.15 %$ 0.275  Millions$ 0.348  Millions
Allurion Technologies Inc   79.11 %$ 11.131  Millions$ 14.071  Millions
Surmodics Inc   78.90 %$ 21.460  Millions$ 27.198  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.